Embrey brings extensive executive health and medical experience in federal service as well as military and veteran affairs issues to the board
SAN DIEGO, CA – July 10, 2014 – Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services globally, announced that Ellen Embrey, B.S., has joined its strategic advisory board. Embrey earned a bachelor’s degree from Virginia Tech and was twice awarded the Department of Defense (DOD) Distinguished Civilian Service Award. Embrey brings extensive executive health and medical experience in federal service as well as military and veteran affairs issues to the board.
Embrey acted as the Assistant Secretary of Defense for Health Affairs and the Director of TRICARE Management Activity during the presidential transition period in 2009-2010. She was also the Deputy Assistant Secretary of Defense for Force Health Protection and Readiness, leading significant changes in DOD policies and programs affecting deployment and combat casualty medicine, health promotion and preventive medicine, medical readiness and public health emergency preparedness and response.
“I am passionate about discovering the best possible health promotion, prevention and treatment services for America’s service members, veterans, and their families,” said Embrey. “Pathway’s cutting-edge testing provides an exquisite opportunity for care providers in both DOD and VA systems of care to understand and leverage patient-specific genetic information to design effective and personalized prevention and treatment programs for common health issues such as obesity, depression, pain management, and cancer.”
Embrey is currently CEO of Stratitia Inc., a firm providing medical logistics, scientific and technical subject matter experts, program and project management, management consulting, strategic planning, and health facility planning and design services in the healthcare, IT management, and emergency response preparedness sectors.
“We’re very fortunate to have someone as widely respected and accomplished as Ellen on our advisory board,” said Jim Plante, Pathway Genomics CEO. “Now that Pathway is a certified contractor to the federal government, having the benefit of Ellen’s guidance and experience are invaluable in helping to ensure the military and veteran community has widespread availability of these critical new healthcare tools.”